CH-VAD

DEVICE2 trials

Sponsors

Beijing Anzhen Hospital, China National Center for Cardiovascular Diseases

Conditions

Heart FailureHemocompatibility-related Adverse Event

Unknown Phase

Outcomes of a Novel Magnetically Levitated LVAD: a Multicenter Analysis

CompletedNCT06596499

Beijing Anzhen HospitalHeart Failure

Start: 2022-06-01End: 2024-08-01Updated: 2024-09-26

Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD

CompletedNCT07343102

China National Center for Cardiovascular DiseasesHemocompatibility-related Adverse Event

Start: 2022-08-01End: 2025-11-20Updated: 2026-01-15